What is Spravato (esketamine)?
Spravato (esketamine) is a prescription nasal-spray treatment approved by the FDA for adults with treatment-resistant depression, used alongside an oral antidepressant. It is regulated under a federal program that requires it to be given in a certified healthcare setting, under direct observation, with a monitoring period after each dose. You can read the manufacturer's program details at the Spravato REMS site.
Where do I receive Spravato?
You receive Spravato at our Burien office. It is given and monitored in person because the treatment requires a certified administration setting under federal rules. Burien is the office where we provide it, so the conversation and the treatment both happen there.
How do I know if Spravato is right for me?
Whether Spravato is appropriate is a clinical decision a provider makes after an evaluation. We will not tell you it is right for you before meeting you. The first step is a conversation about your history and what you have already tried, and the provider helps you understand your options from there.
Do you take my insurance for Spravato?
We accept Kaiser, Premera, Regence, Aetna, UnitedHealthcare and Cigna for psychiatric care. Coverage for Spravato specifically depends on your plan and often involves a prior-authorization step, so we can help you check what your plan covers rather than promising coverage we cannot confirm in advance.
What happens during a treatment visit?
You receive the treatment at the Burien office and then stay for a monitoring period afterward, because the supervised in-office setting is part of how Spravato is given safely. You will need a ride home rather than driving yourself, and we talk through those logistics with you ahead of time.
Is Spravato the same as ketamine therapy?
Spravato is a specific FDA-approved esketamine product given under a federal REMS program in a certified setting, which is different from the various ketamine offerings at standalone clinics. We describe it factually, and the best way to understand the difference for your situation is a conversation with a provider.
How soon can I be seen?
The first conversation is available the same week. The treatment itself begins only after an evaluation, since whether Spravato is appropriate is a clinical decision made by a provider. You can start with general psychiatry and medication management while you and your provider talk it through.